The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so in some of these ongoing trials we're looking at disease free survival which is a well accepted endpoint uh we're looking at a pathologic complete response to the um uh uh Intervention which is another accepted one whether or not circulating tumor cells circulating tumor DNA might become an accepted endpoint demonstrating a clinical benefit uh we'll see where where that goes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.